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The investigations of Landsteiner and others have demonstrated 
that in anaphylaxis the significance ascribed to proteins has to be re- 
considered.  The  component  part  of  the  antigen  responsible  for 
specificity need not necessarily be a protein but may be a chemically 
definite simple compound (hapten).  The haptens react in vitro with 
antibodies, and can, under certain circumstances, prevent anaphylactic 
reaction with the full antigen (inhibition reaction (1)) (Jadassohn and 
Schaaf (2)).  Landsteiner (3) also succeeded in inducing anaphylactic 
shock by means of chemically definite compounds (resorcinoldisazo-p- 
succinanilic  acid  and  resorcinoldisazo-p-suberanilic acid)  in  appro- 
priately  sensitized animals.  It  seems,  however,  that  the  protein 
component plays an important part in inducing anaphylactic shock; 
usually the chemically definite compound does not suffice, but must 
be coupled with some protein. 
Since haptens alone do not usually suffice to sensitize, it is generally 
understood that proteins, serving as carriers,  play an important r61e 
in sensitization, the so called full antigen (hapten +  protein) being 
necessary.  For  clinical  medicine,  especially  for  dermatology,  the 
establishment of these facts presents a problem.  We are inclined to 
conceive certain forms of skin hypersensitiveness, especially of the 
urticarial  type,  as  anaphylactic  (Jadassohn).  However,  not  only 
proteins can induce such reactions but, and this is of special impor- 
tance, sensitization can often be produced also by protein-free com- 
pounds of known chemical constitution (drugs).  As  early as  1907 
Wolff-Eisner  (4)  evolved a  hypothesis to  clarify  this  problem by 
assuming that the protein molecules couple with the drug within the 
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organism, thus producing a  full antigen and causing  hypersensitive- 
ness.  Obermayer and Pick (5) had already ascertained that proteins 
derived  from the  same species would  become heterologous  (koerper- 
fremd)  by  iodination,  nitration  or  diazotization,  and  these  facts 
Wolff-Eisner had adduced as a corroboration of his hypothesis.  Pro- 
teins altered in this manner induce in the animal organism the same 
reactions as if heterologous protein had been injected.  Landsteiner 
found later  that azoproteins can induce in rabbits  the formation of 
antibodies which react in vitro specifically with the azo  component 
(hapten), even if they  had been prepared with serum from the same 
species. 
EXPE~ENTAL 
Jadassohn and Schaaf were in  some cases able to sensitize guinea 
pigs by means of diazotized  atoxyl  coupled  with guinea pig serum, 
i.e. without heterologous protein.  These experiments have not as yet 
been published in detail but have been briefly mentioned (6).  One of 
these tests follows below. 
Guinea Pig 16-63.--0n the 1st, 7th, 14th and 21st day intraperitoneal  injec- 
tions of 1.5 cc. diazotized atoxyl coupled with guinea pig serum (prepared  ac- 
cording to Landsteiner)  were given; on the 49th day the Schultz-Dale test was 
made (7). 
The curve in Fig.  1 deafly demonstrates that the animal treated 
previously with diazotized atoxyl coupled with guinea pig serum has 
been sensitized to this substance.  No heterologous protein had been 
used,  either  for  the  sensitization  or  for  eliciting  the  anaphylactic 
response. 
Undoubtedly all  these  facts seem in good agreement with Wolff- 
Eisner's  hypothesis.  There  still  remains  the  important  point  of 
actual proof that within the organism the  chemically definite com- 
pound couples with the body protein and that such a coupling product 
of the organism itself is then able to sensitize.  The foUowing experi- 
ments appear to confirm this idea.  The sodium salt of atoxyl-diazo- 
amino-sulfoanthranilic  acid  (2-carboxy-4-sulfodiazoaminobenzene-4- 
arsenic acid), H.  E.  ~FIERZ,  W.  JADASSOHN~  AND  W.  STOLL 
H~Ov~_s--~--N=N--NH--~--SO~H 
I 
COOH 
was  used  for this purpose. 
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FIG.  1.  Above, left horn; below, right horn.  A  =  0.4 cc. of 1 per cent guinea 
pig serum-azoprotein.  B  =  0.4 cc, of 1 per cent rabbit serum-azoprotein.  P  = 
1 cc. pituglandol 1 : 250.  x  =  rinsing. 
Preparation and Properties.--5.86  gm.  atoxyl dissolved in 30  cc. N/1  HC1 and 
cooled  to  about  0°C.  were diazotized  with  20  cc.  of  N/1  nitrite  solution.  The 
resulting  diazo  compound  was  slowly stirred  into  a  neutral  solution  of  4.6  gm. 
6-amino-3-sulfobenzoic acid  plus  6  gin.  sodium  acetate  in  150  cc.  of  water,  the 
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and finally neutralized with Na2COa.  After the coupling was completed, the solu- 
tion  was heated  for a  short  time to  50°C.,  then  50 gm.  of pure sodium  chloride 
were added  and  the mixture  kept  at 0 °.  Soon  the diazoamino compound  sepa- 
FIG.  2.  Guinea  pig  4-54,  previously treated  with  sodium  atoxyl-diazoamino- 
sulfoanthranilate.  Schultz-Dale  experiment  on  the 54th  day. 
Above, left horn; below, right horn.  A.H.  =  i0 mg. atoxyl-azo-chicken serum. 
B  =  50 rag. sodium atoxyl-diazoamino-sulfoanthranilate.  P  =  1 cc. pituglandol 
1:250.  x  =  rinsing. 
rated  from  the  solution  in  fine  yellow  crystals.  After  two  recrystallizations 
from water the substance was dried in vacuo at 50  °. 
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a yellow  solution.  In the dry state and in alkaline solution it is quite stable.  On 
acidification of an aqueous solution with acetic acid the diazonium salt of p- 
arsanilic acid is liberated.  This compound  is then able to couple  with appropriate 
substances to form real asodyes and  also with proteins to yield colored azo- 
proteins. 
Preparatory Treatment of Guinea Pigs.--A 1 per cent solution of sodium atoxyl- 
diazoamino-sulfoanthranilate in physiological sodium chloride solution was in- 
jected intraperitoneally at weekly intervals for 4 weeks.  The first three injec- 
tions were 2 ce. each, the last injection 4 ce.  52 to 88 days after the injections the 
Schultz-Dale test was performed (7).  Of the 13 treated guinea pigs 3 had died; 
the remainder were tested.  5 of these were also tested for an anaphylactic reac- 
tion with the sodium atoxyl-diazoamino-sulfoanthranilate  which had been used 
in the preliminary treatment and all of them were tested for anaphylactic reaction 
with diazotized atoxyl coupled with chicken serum (prepared according to Land- 
steiner). 
RESULTS 
1.  None  of  the  5  animals  gave  an  anaphylactic  reaction  with 
sodium  atoxyl-diazoamino-sulfoanthranilate (10-100  mg.  per  50  cc. 
bath solution). 
2.  All  10  animals  responded  to  the  atoxyl azoprotein  with  an 
anaphylactic reaction (contraction of the uterus  with 2.5-10 mg.  (in 
50 cc. bath solution)  which upon repeated contact did not reappear 
(neutralization). 
3.  By sodium atoxyl-diazoamino-sulfoanthranilate the subsequent 
reaction with the azoprotein was,  with one exception, not interfered 
with.  These  and  other  experiments  on  neutralization will be  dis- 
cussed later. 
To illustrate these experiments, a curve is reproduced in Fig. 2. 
DISCUSSION 
Sodium  atoxyl-diazoamino-sulfoanthranilate injected  into  guinea 
pigs sensitizes the animals not to this compound but to an azoprotein 
corresponding to it.  At present, for this behavior there seems to be 
only one satisfactory  explanation.  The diazo compound formed in the 
organism from the sodium atoxyl-diazoamino-sulfoanthranilate used 
in the preliminary treatment recouples to produce an azoprotein which 
sensitizes.  The  Schultz-Dale  test  clearly  indicates  this  azoprotein 
hypersensitiveness.  By  itself,  the  chemically  definite  compound 
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the conditions of the test formation of azoprotein in the uterus occurs 
not quickly enough or not at all. 
We therefore have reached the following conclusions.  Chemically 
definite compounds can sensitize animals in the same way as chemically 
definite  compounds  (drugs)  can  sensitize  human  beings.  In  this 
process coupling of the chemically definite compound with the body 
protein takes place and it is the coupled product  which  sensitizes. 
The  hypersensitiveness  caused  in  this  manner  cannot  be  demon- 
strated with the chemically definite compound used in the preliminary 
treatment but only by an anaphylactic reaction with the correspond- 
ing azoprotein.  The proof of the formation of this azoprotein in vivo, 
however, makes it  quite likely that  chemically definite compounds 
not  only can produce anaphylactic hypersensitiveness but  that,  in 
conjunction with the body protein, they can also induce in the organ- 
ism anaphylactic reaction.  For at least some cases this is a confirma- 
tion of the Wolff-Eisner hypothesis.  The proof that sensitization is 
possible without t.he use of heterologous protein is, however, also of 
importance  for  the  whole  conception  of  anaphylaxis.  Especially 
striking is  the  fact  that  a  non-anaphylactogenic substance  can be 
transmuted by the organism itself into an anaphylactogenic compound 
and that the body protein plays an important part in this process. 
SIFMMA~Y 
Injection of sodium atoxyl-diazoamino-sulfoanthranilate into guinea 
pigs produces an anaphylactic hypersensitiveness to the corresponding 
azoprotein (Schultz-Dale test).  This leads to the conclusion that the 
injected sodium atoxyl-diazoamino-sulfoanthranilate first decomposes 
and then couples in vivo with the body protein to form the correspond- 
ing azoprotein and that therefore it is this compound, produced within 
the organism itself, which sensitizes. 
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